Tu Xu

Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia

Courtney D. DiNardo, Keith W. Pratz, Vinod Pullarkat et al. · Blood · 2018 · 1.9K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study

Courtney D. DiNardo, Keith W. Pratz, Anthony Letai et al. · The Lancet Oncology · 2018 · 712 citations

Medicine, Hematology, Pharmacology +9

Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study

Andrew H. Wei, Stephen A. Strickland, Jing-Zhou Hou et al. · Journal of Clinical Oncology · 2019 · 701 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma

Shaji Kumar, Jonathan L. Kaufman, Cristina Gasparetto et al. · Blood · 2017 · 527 citations · Full text

Medicine, Hematology, Immunology +11

Statins enhance efficacy of venetoclax in blood cancers

J. Scott Lee, Andrew W. Roberts, Dennis Juarez et al. · Science Translational Medicine · 2018 · 86 citations · Full text

Medicine, Oncology, Pharmacology +16